Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantifying the Genetic Correlation between Multiple Cancer Types.
Lindström S, Finucane H, Bulik-Sullivan B, Schumacher FR, Amos CI, Hung RJ, Rand K, Gruber SB, Conti D, Permuth JB, Lin HY, Goode EL, Sellers TA, Amundadottir LT, Stolzenberg-Solomon R, Klein A, Petersen G, Risch H, Wolpin B, Hsu L, Huyghe JR, Chang-Claude J, Chan A, Berndt S, Eeles R, Easton D, Haiman CA, Hunter DJ, Neale B, Price AL, Kraft P; PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO. Lindström S, et al. Among authors: eeles r. Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1427-1435. doi: 10.1158/1055-9965.EPI-17-0211. Epub 2017 Jun 21. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28637796 Free PMC article.
Familial cancer syndromes.
Eng C, Stratton M, Ponder B, Murday V, Easton D, Sacks N, Watson M, Eeles R. Eng C, et al. Among authors: eeles r. Lancet. 1994 Mar 19;343(8899):709-13. doi: 10.1016/s0140-6736(94)91585-7. Lancet. 1994. PMID: 7907684 No abstract available.
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.
Eeles RA, Durocher F, Edwards S, Teare D, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Ardern-Jones A, Dowe A, Shearer R, McLellan DL, Norman RL, Ghadirian P, Aprikian A, Ford D, Amos C, King TM, Labrie F, Simard J, Narod SA, Easton D, Foulkes WD. Eeles RA, et al. Am J Hum Genet. 1998 Mar;62(3):653-8. doi: 10.1086/301745. Am J Hum Genet. 1998. PMID: 9497242 Free PMC article.
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA. Gayther SA, et al. Among authors: eeles ra. Cancer Res. 2000 Aug 15;60(16):4513-8. Cancer Res. 2000. PMID: 10969800
Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
Bevan S, Edwards SM, Ardern Jones A, Dowe A, Southgate C, Dearnaley D, Easton DF, Houlston RS, Eeles RA; CRC/BPG UK Familial Prostate Cancer Study Collaborators. Bevan S, et al. Among authors: eeles ra. Prostate Cancer Prostatic Dis. 2003;6(1):12-4. doi: 10.1038/sj.pcan.4500616. Prostate Cancer Prostatic Dis. 2003. PMID: 12664059
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.
Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Muir K, Houlston RS, Engert JC, Roquis D, Sinnett D, Simard J, Heimdal K, Møller P, Maehle L, Badzioch M, Eeles RA, Easton DF, English DR, Southey MC, Hopper JL, Foulkes WD, Giles GG; Cancer Research UK/British Association of Urological Surgeons' Section of Oncology Collaborators. Hope Q, et al. Among authors: eeles ra. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):397-402. doi: 10.1158/1055-9965.EPI-04-0202. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734964 Free article.
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom.
Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, Bancroft E, Short S, Smith I, Gui G; Royal Marsden NHS Foundation Trust; Barr L, Baildam A, Howell A, Royle G, Pierce L, Easton D, Eeles R. Shanley S, et al. Among authors: eeles r. Clin Cancer Res. 2006 Dec 1;12(23):7033-8. doi: 10.1158/1078-0432.CCR-06-1246. Clin Cancer Res. 2006. PMID: 17145825
674 results